Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.
Authors: Verdeyen K; Amsterdam UMC location Universiteit van Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam., Reuvekamp T; Amsterdam UMC location Universiteit van Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam., Van der Velden WJFM; Radboud University Medical Center, Department of Hematology, Nijmegen., Wouters BJ; Erasmus Medical Center, Department of Hematology, Rotterdam., Von dem Borne PA; Leiden University Medical Center, Department of Hematology, Leiden., Van Rhenen A; University Medical Center Utrecht, Department of Hematology, Utrecht., Lissenberg-Witte BI; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam., Van Lammeren D; HagaZiekenhuis, Department of Hematology, The Hague., Van Sluis GL; Isala Clinics, Department of Internal Medicine, Zwolle., De Jongh E; Albert Schweitzer Hospital, Department of Internal Medicine, Dordrecht., Fiets RB; Amphia Hospital, Department of Internal Medicine, Breda., Corsten MF; Meander Medical Center, Department of Hematology, Amersfoort., Van der Spek AC; Northwest Clinics, Department of Internal Medicine, Alkmaar., Gerrits AM; OLVG, Department of Internal Medicine, Amsterdam., Van Bladel ER; Slingeland Hospital, Department of Internal Medicine, Doetinchem., Tick LW; Máxima Medical Centre, Department of Internal Medicine, Veldhoven., De Weerdt O; Sint Antonius Hospital, Department of Hematology, Nieuwegein., Van Zaane B; Flevo Hospital, Department of Internal Medicine, Almere., Cruijsen MJ; Catharina Hospital, Department of Internal Medicine, Eindhoven., Posthuma EFM; Reinier de Graaf Group, Department of Internal Medicine, Delft., Van Elssen CHMJ; Maastricht University Medical Center+, Department of Internal medicine, Maastricht, The Netherlands; Research Institute for Oncology and Reproduction (GROW), Maastricht University, Maastricht., Klein SK; University Medical Center Groningen, Department of Hematology, Groningen., Van de Loosdrecht AA; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam., De Leeuw DC; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam. d.deleeuw@amsterdamumc.nl.
Source: Haematologica [Haematologica] 2026 Mar 01; Vol. 111 (3), pp. 1075-1080. Date of Electronic Publication: 2025 Sep 18.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2025.288178